| Mesenchymal stem cells induce resistance to chemotherapy through the release of platinum-induced fatty acids JML Roodhart, LGM Daenen, ECA Stigter, HJ Prins, J Gerrits, ... Cancer cell 20 (3), 370-383, 2011 | 370 | 2011 |
| Increased levels of viable circulating endothelial cells are an indicator of progressive disease in cancer patients LV Beerepoot, N Mehra, JSP Vermaat, BA Zonnenberg, M Gebbink, ... Annals of oncology 15 (1), 139-145, 2004 | 326 | 2004 |
| Selinexor in patients with relapsed or refractory diffuse large B-cell lymphoma (SADAL): a single-arm, multinational, multicentre, open-label, phase 2 trial N Kalakonda, M Maerevoet, F Cavallo, G Follows, A Goy, JSP Vermaat, ... The Lancet Haematology 7 (7), e511-e522, 2020 | 266 | 2020 |
| Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer WP Kloosterman, M Hoogstraat, O Paling, M Tavakoli-Yaraki, I Renkens, ... Genome biology 12, 1-11, 2011 | 207 | 2011 |
| Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment JS Vermaat, IJ Nijman, MJ Koudijs, FL Gerritse, SJ Scherer, M Mokry, ... Clinical cancer research 18 (3), 688-699, 2012 | 172 | 2012 |
| Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection O Karimi, A Goorhuis, J Schinkel, J Codrington, SGS Vreden, JS Vermaat, ... The Lancet 387 (10022), 939-940, 2016 | 139 | 2016 |
| Cytosolic p120-catenin regulates growth of metastatic lobular carcinoma through Rock1-mediated anoikis resistance RCJ Schackmann, M Van Amersfoort, JHI Haarhuis, EJ Vlug, VA Halim, ... The Journal of clinical investigation 121 (8), 3176-3188, 2011 | 137 | 2011 |
| Late release of circulating endothelial cells and endothelial progenitor cells after chemotherapy predicts response and survival in cancer patients JM Roodhart, MH Langenberg, JS Vermaat, MP Lolkema, A Baars, ... Neoplasia 12 (1), 87-94, 2010 | 90 | 2010 |
| Reduced cilia frequencies in human renal cell carcinomas versus neighboring parenchymal tissue SG Basten, S Willekers, JSP Vermaat, GGG Slaats, EE Voest, ... Cilia 2, 1-8, 2013 | 84 | 2013 |
| High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma AMR Schrader, PM Jansen, R Willemze, MH Vermeer, AM Cleton-Jansen, ... Blood, The Journal of the American Society of Hematology 131 (18), 2086-2089, 2018 | 75 | 2018 |
| IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling PC Maity, M Bilal, MT Koning, M Young, CAM van Bergen, V Renna, ... Proceedings of the National Academy of Sciences 117 (8), 4320-4327, 2020 | 70 | 2020 |
| MYD88 in the driver’s seat of B-cell lymphomagenesis: From molecular mechanisms to clinical implications RAL de Groen, AMR Schrader, MJ Kersten, ST Pals, JSP Vermaat haematologica 104 (12), 2337, 2019 | 65 | 2019 |
| Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C β-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced … JM Rademaker-Lakhai, LV Beerepoot, N Mehra, SA Radema, ... Clinical cancer research 13 (15), 4474-4481, 2007 | 65 | 2007 |
| MYD88 mutations identify a molecular subgroup of diffuse large B-cell lymphoma with an unfavorable prognosis JS Vermaat, SF Somers, LC de Wreede, W Kraan, RAL de Groen, ... Haematologica 105 (2), 424, 2020 | 64 | 2020 |
| Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencing W Arindrarto, DM Borràs, RAL de Groen, RR van den Berg, IJ Locher, ... Leukemia 35 (1), 47-61, 2021 | 56 | 2021 |
| Two-protein signature of novel serological markers apolipoprotein-A2 and serum amyloid alpha predicts prognosis in patients with metastatic renal cell cancer and improves the … JS Vermaat, I van der Tweel, N Mehra, S Sleijfer, JB Haanen, ... Annals of oncology 21 (7), 1472-1481, 2010 | 53 | 2010 |
| High incidence and clinical significance of MYC rearrangements in primary cutaneous diffuse large B-cell lymphoma, leg type AMR Schrader, PM Jansen, MH Vermeer, JK Kleiverda, JSP Vermaat, ... The American journal of surgical pathology 42 (11), 1488-1494, 2018 | 49 | 2018 |
| Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter phase II HOVON trial MED Chamuleau, CN Burggraaff, M Nijland, K Bakunina, R Mous, ... haematologica 105 (12), 2805, 2020 | 41 | 2020 |
| Expression of nuclear FIH independently predicts overall survival of clear cell renal cell carcinoma patients SGC Kroeze, JS Vermaat, A Van Brussel, HHE Van Melick, EE Voest, ... European journal of cancer 46 (18), 3375-3382, 2010 | 37 | 2010 |
| Intravitreal injection of TIMP3 or the EGFR inhibitor erlotinib offers protection from oxygen-induced retinopathy in mice NJ Hewing, G Weskamp, J Vermaat, E Farage, K Glomski, S Swendeman, ... Investigative ophthalmology & visual science 54 (1), 864-870, 2013 | 36 | 2013 |
